Opendata, web and dolomites
H2020 projects about "vaccination"
The page lists 114 projects related to the topic "vaccination".
| # | |||
|---|---|---|---|
| 1 | APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy | 2015 |
| 2 | I-MOVE-plus | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | 2015 |
| 3 | MycoSynVac | Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine | 2015 |
| 4 | ComBact | How complement molecules kill bacteria | 2015 |
| 5 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 6 | Vaccinesurvey | Monitor population immunity against vaccine preventable diseases | 2015 |
| 7 | NanoPilot | A Pilot Plant for the Production of Polymer based Nanopharmaceuticals in Compliance with GMP | 2015 |
| 8 | EpiNKT | Transcriptional and epigenetic control of innate-like T lymphocyte development | 2015 |
| 9 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
| 10 | WORMTUMORS | Worm power: Can helminths modify the development of colorectal cancer? | 2015 |
| 11 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
| 12 | SchmaVirusVacDiag | Novel vaccine and diagnostic strategies against Schmallenberg virus | 2015 |
| 13 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 14 | EbolaVac | Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine | 2014 |
| 15 | FACTs | Fast Acting Virus Control Strategies for Production Animal Diseases | 2015 |
| 16 | TWILIGHT | ToWards Immunisations that Last: the Immunology and Gerontology of Helper T cells | 2015 |
| 17 | MucoVac | Unravelling the mode of action of mucosal adjuvants | 2016 |
| 18 | EVOLPROOF | Are HPV vaccines ‘evolution-proof’? Multilevel evolutionary ecology of human oncoviruses | 2015 |
| 19 | GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines | 2015 |
| 20 | StableVax | Commercialisation of a world changing invention for the stabilisation and delivery of vaccines | 2015 |
| 21 | NEURIMMUNE | Neural regulation of immunity | 2015 |
| 22 | MYCOCHASSIS | Engineering of a minimal bacterial therapeutic chassis | 2015 |
| 23 | BROADimmune | Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens | 2015 |
| 24 | SAL ETHVI | Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI | 2016 |
| 25 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 26 | MCNTMTDC | Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours | 2017 |
| 27 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 28 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
| 29 | GutBCells | Cellular Dynamics of Intestinal Antibody-Mediated Immune Response | 2016 |
| 30 | Immune Regulation | How Infection History Shapes the Immune System: Pathogen-induced Changes in Regulatory T Cells | 2016 |
| 31 | Antibodyomics | Vaccine profiling and immunodiagnostic discovery by high-throughput antibody repertoire analysis | 2016 |
| 32 | VIREX | Mumps VIRus EXploitation of the human adhesion receptor GPR125 | 2016 |
| 33 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 34 | VGAP | The Viral Genome Associated Proteome | 2017 |
| 35 | VACCELERAID | A novel vaccine technology leading to accelerated availability of vaccines and improved delivery | 2016 |
| 36 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 37 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 38 | STRUGGLE | Statistical physics of immune-viral co-evolution | 2017 |
| 39 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 40 | GD TCR LIGAND | Identification of the ligand of a human public anti-HCMV/cancer γδ T cell receptor | 2017 |
| 41 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 42 | PE-FECATS | Pasteur's Empire - French Expertise, Colonialism, and Transnational Science | 2017 |
| 43 | FusionPAMPs | New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants | 2017 |
| 44 | VSV-EBOVAC | Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 | 2015 |
| 45 | EBOMAN | Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850 | 2014 |
| 46 | EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847 | 2014 |
| 47 | PERISCOPE | PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 | 2016 |
| 48 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 49 | SAREE | The Social Anthropology of Rabies Epidemiology and Elimination | 2018 |
| 50 | TEMUBLYM | Teleost mucosal B1-like lymphocytes at the crossroad of tolerance and immunity | 2017 |
| 51 | BoVLP-BVD | Development of Tagged (DIVA), Virus-Like-Particle polyantigenic Vaccine against Bovine Viral Diarrhea virus (BVDc) | 2017 |
| 52 | PALE-Blu | Understanding pathogen, livestock, environment interactions involving bluetongue virus | 2017 |
| 53 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
| 54 | AUTOCOMPLEMENT | The role of complement in the induction of autoimmunity against post-translationally modified proteins | 2017 |
| 55 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 56 | Super-Vaccine | Exploring the potential applications of live viral vaccine encoded small-hairpin-RNAs in improving both vaccine safety and efficacy through RNA-interference and stimulation of the innate immune system | 2018 |
| 57 | VSV-EBOPLUS | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | 2016 |
| 58 | DRIVE | Development of Robust and Innovative Vaccine Effectiveness | 2017 |
| 59 | TREAT-NPM1-AML | Improving therapy of NPM1-mutated AML | 2017 |
| 60 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 61 | TissueLymphoContexts | Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts | 2018 |
| 62 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 63 | mABSPN | Antibody-based therapy against Streptococcus pneumoniae | 2018 |
| 64 | MISTRO | Identification of the cellular sites of cytomegalovirus latency that contribute to the induction of inflationary CD8 T cell memory against the virus. | 2018 |
| 65 | FluPRINT | Tracing the inFLUenza vaccine imPRINT on immune system to identify cellular signature of protection | 2018 |
| 66 | ENGEMED | Simulating the dynamics of viral evolution: A computer-aided study toward engineering effective vaccines | 2018 |
| 67 | GammaDelta | DECIPHERING THE MEMORY OF gd T CELLS: DOES IT HAVE A ROLE IN CROSS-PROTECTION OF BACILLE CALMETTE-GUERIN VACCINATION? | 2018 |
| 68 | MAGIC | Magnification of Asthma by human memory Group 2 Innate lymphoid Cells | 2018 |
| 69 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 70 | HPV OncoPredict | A Groundbreaking Stand-Alone Diagnostic Kit to Predict Human Papilloma Virus Infections Evolving into Cervical Cancer | 2018 |
| 71 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 72 | BGV1 | New vaccine for a paradigm shift in Brucellosis | 2018 |
| 73 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 74 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 75 | SyrinJector | SyrinJector, the first smart device for livestock mass vaccination. | 2018 |
| 76 | ELEVATE | Early detection of cervical cancer in hard-to-reach populations of women through portable and point-of-care HPV testing | 2019 |
| 77 | MycoVAP | Bacterial chassis for treating ventilator-associated pneumonia (VAP) | 2019 |
| 78 | FuncMAB | High-throughput single-cell phenotypic analysis of functional antibody repertoires | 2019 |
| 79 | QSEIF | QSEIF: The new pathogen, DNA and immunological testing platform | 2019 |
| 80 | VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation | 2019 |
| 81 | EV-2C | Structural and functional studies of enterovirus 2C proteins: promising targets for antiviral therapy. | 2019 |
| 82 | DIFTERIA | Development of a simple and rapid assay for early diphtheria diagnosis. | 2020 |
| 83 | EpIg Men | The Role of Antibodies (Ig) and the Respiratory Epithelium in the Prevention of Invasive Meningococcal Infections in Different Age Groups | 2019 |
| 84 | FAKEOLOGY | Fake news and pseudo-science as post-modern mythology: The case of the anti-vaccination movement | 2019 |
| 85 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 86 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 87 | DISCOURSEVAX | Institutional Theory and Discourse Analysis: an empirical investigation of the rhetoric of Anti Vaccination movement | 2020 |
| 88 | BoVLP-BVD | Tagged (DIVA) polyantigenic vaccine against Bovine Viral Diarrhea virus (BVDv) based on virus-Like-Particles | 2019 |
| 89 | STOPTHEFRAUDINOLIVEO | Fighting counterfeiting in Olive Oil with blockchain - a working product has arrived | 2019 |
| 90 | MIBEst | Molecular Infection Biology Estonia - Research capacity building | 2019 |
| 91 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 92 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 93 | VACDIVA | A safe DIVA vaccine for African Swine Fever control and eradication | 2019 |
| 94 | TRAIN-OLD | Trained immunity: improving the next generation of vaccines for the older generation | 2019 |
| 95 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
| 96 | B-DOMINANCE | B Cell Immunodominance in Antiviral Immunity | 2019 |
| 97 | VIVA | Vaccine development against variable pathogens | 2020 |
| 98 | RARITY | RAtional design of canceR ImmunoTherapY: one size does not fit all | 2019 |
| 99 | RISCC | RISK-BASED SCREENING FOR CERVICAL CANCER | 2020 |
| 100 | TherVacB | THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B | 2020 |
| 101 | DPR-VAX | Dipeptide-Repeat Vaccine to prevent ALS and FTD in C9orf72 mutation carriers | 2020 |
| 102 | ISOLDA | Improved Vaccination Strategies for Older Adults | 2020 |
| 103 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |
| 104 | ENDFLU | Evaluation of ratioNally Designed Influenza vaccines | 2020 |
| 105 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 106 | CELLULO-EPI | Celluloepidemiology: a novel paradigm for modeling T-cell responses on a population level. | 2020 |
| 107 | PreventALL | Prevention of childhood Acute Lymphoblastic Leukemia immunology links oncology | 2020 |
| 108 | BGV1 | New vaccine for a paradigm shift in Brucellosis, one of the world’s most widespread zoonotic diseases affecting humans | 2020 |
| 109 | Valvax | Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination | 2020 |
| 110 | DYNAMOD-VACCINE-DATA | A new method for dynamic opinion modelling of surveys applied to vaccine hesitancy data | 2020 |
| 111 | EPmIC | Controlling the susceptibility of biological cells to pulsed electric field treatment by using ion channel modulators | 2021 |
| 112 | VacTrack | Dissecting the protection mechanism of new generation vaccines by synchronizing systems biology with in vivo imaging | 2021 |
| 113 | FluAttack | Validation of a novel antiviral drug candidate against influenza | 2020 |
| 114 | SupraRNA | A Comprehensive Supramolecular Approach for an RNA vaccine for Influenza A (H1N1) | 2020 |